CN1969959A - Externally applied medicament for treating bone fracture - Google Patents

Externally applied medicament for treating bone fracture Download PDF

Info

Publication number
CN1969959A
CN1969959A CNA2006101671028A CN200610167102A CN1969959A CN 1969959 A CN1969959 A CN 1969959A CN A2006101671028 A CNA2006101671028 A CN A2006101671028A CN 200610167102 A CN200610167102 A CN 200610167102A CN 1969959 A CN1969959 A CN 1969959A
Authority
CN
China
Prior art keywords
medicine
cortex
effect
bone fracture
fracture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2006101671028A
Other languages
Chinese (zh)
Other versions
CN100551390C (en
Inventor
洪之伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006101671028A priority Critical patent/CN100551390C/en
Publication of CN1969959A publication Critical patent/CN1969959A/en
Application granted granted Critical
Publication of CN100551390C publication Critical patent/CN100551390C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses an externally used medicament for treating bone fracture which is prepared from raw materials of native copper, drynaria, dipsacus root, Garter snake, wood louse, frankincense, mulberry bark, mimosa-tree bark and Cinnamomum cassia by a predetermined weight proportions.

Description

The medicine for external use of treatment fracture
Technical field
The invention belongs to Chinese medicine unguentum field, the medicine for external use of treatment fracture specifically.
Background technology
Fracture is that phalanges and bone trabecular seriality are interrupted, and the integrity of skeleton suffers destructive a kind of sign, generally by due to the external force, is disease more serious in the traumatology.
The method of treatment fracture at present, doctor trained in Western medicine is general adopt with after the reduction with clamping plate or external plaster fixation and be aided with necessary interior medicine for external use, the patient suffering is big, and healing is slow.The tradition traditional Chinese medical science is taken Drug therapys such as Cortex torricelliae tiliifoliae, XINSHANGXUJIN TANG more, and medicine time is long, takes inconvenience, and it is fried that effective ingredient is difficult for, so curative effect is undesirable.
Purpose of the present invention is to provide a kind of Chinese medicine preparation for the treatment of fracture, but blood circulation promoting and blood stasis dispelling, promoting of the circulation of QI and removing the obstruction in the collaterals, reducing swelling and alleviating pain, reunion of bone reach the purpose of treatment fracture.Medicine of the present invention is formulated by pure Chinese medicine, has no side effect, and is evident in efficacy, and effective percentage reaches 100%, and cure rate reaches 90%.
Summary of the invention
Solution of the present invention is based on the pathology understanding of motherland's medical science to fracture, in conjunction with modern pharmacology research, select for use invigorate blood circulation, the medicine of dissipating blood stasis, reunion of fractured tendons and bones cold expelling, blood circulation promoting and blood stasis dispelling forms through certain proportioning prescription, has no side effect, and is evident in efficacy, lasting.
Prescription of the present invention and material medicine deal are as follows:
Pyritum 2-20, Rhizoma Drynariae 5-25, Radix Dipsaci 5-25, Ophisaurus 3-20, Eupolyphaga Seu Steleophaga 5-25, Olibanum 3-20, Cortex Mori 5-20, Cortex Albiziae 5-20, Cortex Cinnamomi 0.2-1.0, Moschus 0.2-1.5, Myrrha 3-20, Flos Carthami 3-10, Plumbum preparatium 130-170.
Drug action mechanism of the present invention is as follows:
Pyritum: hot, flat, return Liver Channel.The effect that has eliminating stasis to stop pain, synthetism to cure the wound.(China Traditional Chinese Medicine Publishing House publishes for " Chinese materia medica " 391 pages, Gao Xuemin chief editor, and JIUYUE was the 1st edition in 2000, in January, 2004 the 4th printing.)
Rhizoma Drynariae: bitter, warm, return liver, kidney channel, the effect of invigorate blood circulation continuous wound, the kidney invigorating bone strengthening is arranged.(the same 393 pages.)
Radix Dipsaci: bitter, hot, tepor, return liver, kidney channel.Liver and kidney tonifying, strengthening the tendons and bones, arresting bleeding and miscarriage prevention are arranged, the continuous discharging the retained water effect of curing the wound.(the same 521 pages.)
Ophisaurus: become, put down, return the liver,kidney,spleen warp, the effect of dissipating blood stasis synthetism, expelling wind and removing dampness is arranged.(Sichuan science tech publishing house published in 1985 for " practical traumatology Chinese medicine and prescription " 75 pages, Zheng Huaixian, Ran Dezhou chief editor.)
Eupolyphaga Seu Steleophaga: salty, cold, slightly poisonous, return Liver Channel.The effect that removing blood stasis, reunion of fractured tendons and bones are arranged.(China Traditional Chinese Medicine Publishing House publishes for " Chinese materia medica " 389 pages, Gao Xuemin chief editor, and JIUYUE was the 1st edition in 2000, in January, 2004 the 4th printing.)
Olibanum: hot, bitter, warm, GUIXIN, liver, spleen channel.The effect that promoting blood circulation and stopping pain, detumescence and promoting granulation are arranged.(the same 369 pages.)、
Cortex Mori: sweet, cold, return lung meridian.The effect that eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema are arranged.(the same 439 pages.)
Cortex Albiziae: sweet, flat, GUIXIN, liver, lung meridian.The effect that resolving stagnation for tranquilization, promoting blood circulation and detumescence are arranged.(the same 460 pages.)
Cortex Cinnamomi: hot, sweet, big heat is returned kidney, spleen, the heart, Liver Channel.Have mend that fire is supporing yang, the effect of dispersing cold for relieving pain, warming the meridian and promoting blood circulation, conducting fire back to its origin.(the same 276 pages.)
Moschus: hot, warm, GUIXIN, spleen channel have the effect of the refreshment of having one's ideas straightened out, promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain.(the same 487 pages.)
Myrrha: hot, bitter, flat, GUIXIN, liver, spleen channel.The effect that promoting blood circulation and stopping pain, detumescence and promoting granulation are arranged.(the same 371 pages)
Flos Carthami: hot, warm, GUIXIN, Liver Channel have the effect of promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing.(the same 377 pages.)
The Plumbum preparatium: suffering, be slightly cold, poisonous, GUIXIN, Liver Channel.The effect that removing toxic substances and promoting tissue regeneration, killing parasites for relieving itching are arranged.(the same 609 pages.)
Motherland's medical science thinks, fracture is mainly due to the external violence, the fracture injury of tendon and muscle, limb injury in outside, and QI and blood is decreased in interior, blood stasis is stagnated, QI and blood is not smooth, swelling pain, meridians are obstructed, stagnation of QI and blood may bring about pain.Chinese medicine is thought simultaneously, the treatment fracture will be from organic conception, according to the pathology in the fracture healing process, physiological characteristics, use that dialectical opinion is controlled, internal and external application, muscles and bones are laid equal stress on, the local and whole Therapeutic Principle who combines, to catch the main aspect of pathological changes during medication, send medicine with the disease prescription, can reach therapeutic purposes.In the medicine of the present invention, first with Olibanum, Myrrha, Flos Carthami circulation of qi promoting, invigorate blood circulation, blood stasis dispelling, stimulate the menstrual flow, pain relieving, be equipped with that Cortex Albiziae, Cortex Mori are invigorated blood circulation, detumescence, diuretic.With Pyritum, Rhizoma Drynariae dissipating blood stasis, invigorate blood circulation the synthetism of curing the wound.Modern pharmacology proves that Rhizoma Drynariae has certain effect that improves chondrocyte function, postponement cell degeneration, can promote the absorption of bone to calcium, the level of increasing blood calcium and serium inorganic phosphorus, the healing that helps fracturing.Radix Dipsaci, Ophisaurus, Eupolyphaga Seu Steleophaga energy liver and kidney tonifying, reunion of bone, strengthening the tendons and bones.With Cortex Cinnamomi dispersing cold for relieving pain, promoting the flow of QI-blood by warming the meridian.Moschus can be had one's ideas straightened out and be stimulated the menstrual flow, walks to scurry collateral dredging, draws all medicines and reaches disease institute.Plumbum preparatium can draw out pus by applying a plaster to the affected part removing the necrotic tissue and promoting granulation, removing dampness killing parasites for relieving itching are the raw material of preparation plaster again.All medicines are synthetic, and energy blood circulation promoting and blood stasis dispelling, stimulate the menstrual flow only network, reducing swelling and alleviating pain, relaxing muscles and tendons and activating QI and blood in the collateral, reunion of bone reach the purpose that treatment is fractured.
The specific embodiment
The present invention will be further described below in conjunction with embodiment.
Get Pyritum 5g, Rhizoma Drynariae 5g, Radix Dipsaci 5g, Ophisaurus 5g, Eupolyphaga Seu Steleophaga 5g, Olibanum 10g, Cortex Mori 5g, Cortex Albiziae 5g, Cortex Cinnamomi 0.3g, Moschus 1g, Myrrha 10g, Flos Carthami 5g, Plumbum preparatium 150g.With Rhizoma Drynariae, Radix Dipsaci, Ophisaurus, Eupolyphaga Seu Steleophaga, Olibanum, Myrrha, Flos Carthami, impregnated in the 300g Oleum sesami 5-7 days, put in the iron pan then and fry with slow fire, fried to half-mature, descend Cortex Mori, Cortex Albiziae, Cortex Cinnamomi again, all with spice fried withered degree of being, elimination medicine and impurity then.Get filterable medicine oil and put in the pot, refine oil with high heat to smog and spin round and round at pasta, and constantly stir, with medicine oil droplet Cheng Zhu in water be degree that do not loose, subtract fire then and add Plumbum preparatium, the limit edged stirs all to bake to pellet and only turns to.Pot is treated when slightly cool from fire, Moschus, the Pyritum back that grinds to the powder is altogether added in the cream mixing and stirring.At last ointment is poured in the cold water, soaked the gas that reduces internal heat and get final product.Take out the plaster piece before facing stand cream, spread out on cloth with the slow fire fusing.During use, with the para-position of patient's fracture, fix with clamping plate, get a certain amount of plaster according to conditions of patients and spread on the affected part and fix, 10 days is a course of treatment, and according to the fracture degree, can fully recover 1-4 the course of treatment.
For showing the curative effect of medicine of the present invention, 100 patients of treatment are divided into test group and matched group execute and control, upright shelves stay to look into follow up survey is added up contrast.Matched group Chinese and western medicine conventional therapy, test group Drug therapy of the present invention all is effectively with the sx, what symptom all disappeared, do not recur after half a year is recovery from illness.Statistical result is as follows:
Table 1: matched group curative effect situation:
Table 2: test group curative effect situation:

Claims (2)

  1. The medicine for external use of 1, treatment fracture is characterized in that;
    It is made up of following raw materials by weight proportions:
    Pyritum 2-20, Rhizoma Drynariae 5-25, Radix Dipsaci 5-25, Ophisaurus 3-20, Eupolyphaga Seu Steleophaga 5-25, Olibanum 3-20, Cortex Mori 5-20, Cortex Albiziae 5-20, Cortex Cinnamomi 0.2-1.0, Moschus 0.2-1.5, Myrrha 3-20, Flos Carthami 3-10, Plumbum preparatium 130-170.
  2. 2. the medicine for external use of treatment fracture according to claim 1 is characterized in that:
    It is made up of following raw materials by weight proportions:
    Pyritum 5g, Rhizoma Drynariae 5g, Radix Dipsaci 5g, Ophisaurus 5g, Eupolyphaga Seu Steleophaga 5g, Olibanum 10g, Cortex Mori 5g, Cortex Albiziae 5g, Cortex Cinnamomi 0.3g, Moschus 1g, Myrrha 10g, Flos Carthami 5g, Plumbum preparatium 150g.
CNB2006101671028A 2006-12-06 2006-12-06 The medicine for external use of treatment fracture Expired - Fee Related CN100551390C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006101671028A CN100551390C (en) 2006-12-06 2006-12-06 The medicine for external use of treatment fracture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006101671028A CN100551390C (en) 2006-12-06 2006-12-06 The medicine for external use of treatment fracture

Publications (2)

Publication Number Publication Date
CN1969959A true CN1969959A (en) 2007-05-30
CN100551390C CN100551390C (en) 2009-10-21

Family

ID=38111107

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006101671028A Expired - Fee Related CN100551390C (en) 2006-12-06 2006-12-06 The medicine for external use of treatment fracture

Country Status (1)

Country Link
CN (1) CN100551390C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101234153B (en) * 2007-12-27 2010-11-10 卢旭 Externally-applied medicament for treating bone fracture
CN102784317A (en) * 2012-07-26 2012-11-21 李厚建 Traditional Chinese medicine composition for treating aphtha
CN103505499A (en) * 2013-01-09 2014-01-15 席安胜 Fracture rapid healing plaster prescription
CN104997846A (en) * 2015-07-02 2015-10-28 王富强 Traditional Chinese medicine composition for treating bone fracture disease

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101234153B (en) * 2007-12-27 2010-11-10 卢旭 Externally-applied medicament for treating bone fracture
CN102784317A (en) * 2012-07-26 2012-11-21 李厚建 Traditional Chinese medicine composition for treating aphtha
CN102784317B (en) * 2012-07-26 2014-02-12 李厚建 Traditional Chinese medicine composition for treating aphtha
CN103505499A (en) * 2013-01-09 2014-01-15 席安胜 Fracture rapid healing plaster prescription
CN104997846A (en) * 2015-07-02 2015-10-28 王富强 Traditional Chinese medicine composition for treating bone fracture disease

Also Published As

Publication number Publication date
CN100551390C (en) 2009-10-21

Similar Documents

Publication Publication Date Title
CN101066442A (en) Externally applied Chinese medicine lotion for treating pain caused by wind, cold and damp
CN104644943A (en) Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method
CN100551390C (en) The medicine for external use of treatment fracture
CN101007040B (en) External applied medicine for treating bone fractures
CN104758743A (en) Traditional Chinese medicine foot fumigating powder for treating rheumatism as well as preparation method and using method thereof
CN103394042A (en) Traditional Chinese medicine tincture used for adjuvant therapy on bone fracture
CN106540229A (en) A kind of exterior-applied medical wine for treating cold pain disease and preparation method thereof
CN105748646A (en) Traditional Chinese medicine composition for treating pain in neck or shoulders or waist or legs and preparation method thereof
CN102218094B (en) Chinese medicinal preparation for treating traumatic injury and preparation method thereof
CN105497779A (en) Traditional Chinese medicine patch for treating acute lumbar sprain
CN105078105A (en) Healthcare traditional Chinese salt pillow
CN101195002B (en) Chinese medicine emplastrum for releasing ache and health care
CN101301447B (en) Chinese medicinal composition for treating epilepsy
CN103989968A (en) Oral traditional Chinese medicinal composition for treating cervical spinal stenosis
CN103585257A (en) Traditional Chinese medicine powder for treating fractures
CN104623540B (en) Ease pain Chinese medicine external medicament, analgesia Traditional Chinese medicinal hot compress bag and making and use method
CN103127349B (en) Medicine for treating traumatic injury
CN101983719A (en) Novel medicament for treating lung cancer
CN106109965A (en) A kind of Chinese medicine composition treating flaccidity disease
CN101953908A (en) Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof
CN106138566A (en) One treats physical fatigue Chinese medicinal liquor and preparation method thereof
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN106214870A (en) A kind of lavipeditum powder treating rheumatic arthritis and preparation method thereof
CN101199682A (en) Medicinal oil medicament for treating anaphylactic dermatitis
CN104587205B (en) A kind of medicine for treating fracture

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091021

Termination date: 20111206